These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2144199)

  • 1. Hepatitis B vaccine associated with erythema nodosum and polyarthritis.
    Rogerson SJ; Nye FJ
    BMJ; 1990 Aug; 301(6747):345. PubMed ID: 2144199
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythema nodosum after Recombivax HB hepatitis B vaccine.
    Goolsby PL
    N Engl J Med; 1989 Oct; 321(17):1198-9. PubMed ID: 2529439
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythema nodosum provoked by hepatitis B vaccine.
    Di Giusto CA; Bernhard JD
    Lancet; 1986 Nov; 2(8514):1042. PubMed ID: 2877208
    [No Abstract]   [Full Text] [Related]  

  • 4. Alleged link between hepatitis B vaccine and chronic fatigue syndrome.
    Can Dis Wkly Rep; 1991 Oct; 17(40):215-6. PubMed ID: 1835672
    [No Abstract]   [Full Text] [Related]  

  • 5. Guillain-Barré syndrome following immunisation with synthetic hepatitis B vaccine.
    Tuohy PG
    N Z Med J; 1989 Mar; 102(863):114-5. PubMed ID: 2522608
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B vaccines: use in childhood.
    Moyes CD
    N Z Med J; 1988 Apr; 101(843):165-6. PubMed ID: 2965800
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination.
    Reutens DC; Dunne JW; Leather H
    Muscle Nerve; 1990 May; 13(5):461. PubMed ID: 2345565
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythema multiforme associated with hepatitis B vaccine.
    Wakeel RA; White MI
    Br J Dermatol; 1992 Jan; 126(1):94-5. PubMed ID: 1531612
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination against hepatitis B: the Heptavax-B and Recombivax-HB vaccines.
    Diaz-Arnold AM; Leary JM
    Dentistry; 1989 Oct; 9(3):21-4. PubMed ID: 2534802
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
    JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B immunisation.
    Kuttner J
    N Z Med J; 1988 May; 101(845):244-5. PubMed ID: 2966906
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reaction to the recombinant hepatitis B vaccine.
    Hudson TJ; Newkirk M; Gervais F; Shuster J
    J Allergy Clin Immunol; 1991 Nov; 88(5):821-2. PubMed ID: 1835467
    [No Abstract]   [Full Text] [Related]  

  • 15. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.
    Herroelen L; de Keyser J; Ebinger G
    Lancet; 1991 Nov; 338(8776):1174-5. PubMed ID: 1682594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.
    Evans DI; Shaw A
    BMJ; 1990 Jun; 300(6741):1694-5. PubMed ID: 2143948
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythema nodosum and hepatitis B: a case report and literature review.
    Wu YL; Tsai MH; Liu LL
    J Microbiol Immunol Infect; 2008 Oct; 41(5):437-9. PubMed ID: 19122928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of hepatitis B vaccine for pre-exposure prophylaxis in health care workers.
    Hutton JP
    Am J Med; 1990 Oct; 89(4):542-3. PubMed ID: 2145763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Verification of the safety, inoculability, reactogenicity and antigenic properties of a live recombinant smallpox-hepatitis B vaccine in an experiment in volunteers].
    Chernos VI; Cheliapov NV; Antonova TP; Rakhilina LE; Unanov SS; Al'tshteĭn AD; Zakharova LG; Fodor II; Bendukidze KA; Komarov FI
    Vopr Virusol; 1990; 35(2):132-5. PubMed ID: 2167564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenicity and safety of hepatitis B virus vaccine (HEPTAVAX-B)].
    Kashiwagi S; Hayashi J; Nomura H; Kajiyama W; Ikematsu H; Ohshima M
    Kansenshogaku Zasshi; 1985 Feb; 59(2):70-6. PubMed ID: 3159813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.